TWD
RYTM icon

True Wealth Design’s Rhythm Pharmaceuticals RYTM Stock Holding History

True Wealth Design’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.3K Hold
147
– – ﹤0.01% 889
2026
Q1 		$12.8K Hold
147
– – ﹤0.01% 894
2025
Q4 		$15.7K Hold
147
– – ﹤0.01% 685
2025
Q3 		$14.8K Hold
147
– – ﹤0.01% 706
2025
Q2 		$9.29K Buy
147
+90
+158% +$5.51K ﹤0.01% 610
2025
Q1 		$3.02K Buy
+57
New +$3.16K ﹤0.01% 857

Other funds holding RYTM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
EWP
Elevation Wealth Partners Santa Rosa, California $334M AUM 26.48% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

True Wealth Design's RYTM Position: Q2 2026 in Review

True Wealth Design held its Rhythm Pharmaceuticals (RYTM) position steady in Q2 2026 at 147 shares worth $16.3K. The position accounts for ﹤0.01% of the portfolio, ranked #889.

True Wealth Design first reported a position in RYTM in Q1 2025 and has held it in 6 quarters since. 20 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • True Wealth Design held 147 shares of Rhythm Pharmaceuticals worth $16.3K as of Q2 2026.
  • True Wealth Design left its Rhythm Pharmaceuticals share count unchanged in Q2 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #889 holding.
  • True Wealth Design first reported a position in Rhythm Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 20 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.